PITX3 Gene Anterior Segment Mesenchymal Dysgenesis NGS Genetic Test
Short Name: PITX3 NGS Genetic Test
Also known as: PITX3 Gene Mutation Analysis, ASMD Genetic Test, Anterior Segment Mesenchymal Dysgenesis NGS Test
PITX3 Gene Anterior Segment Mesenchymal Dysgenesis NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.
🩺 Medically Reviewed By
Dr SULOCHANA HEMCHANDRA HOLLA
Consultant Medical Geneticist · Reg: 8532
Last updated: September 7, 2026
Overview
The purpose of this NGS genetic test is to identify mutations in the PITX3 gene in individuals with clinical features suggestive of anterior segment mesenchymal dysgenesis. It provides a molecular diagnosis, assists in recurrence risk counseling, and helps guide clinical monitoring for associated ocular complications such as glaucoma and cataracts. NGS genetic DNA test detecets for variant and mutation detection in PITX3 gene for Anterior segment mesenchymal dysgenesis
- Test Code
- 3767
- Price
- ₹20,000
- Sample Type
- Blood or Extracted DNA or One drop Blood on FTA Card
- Result Time
- 3 to 4 weeks
- Fasting Required
- No
- Method
- Next-Generation Sequencing (NGS)
Anterior segment mesenchymal dysgenesis (ASMD) is a rare genetic disorder that affects the development of the eye. It is caused by mutations in the PITX3 gene, which provides instructions for making a protein that is important for eye development. ASMD can cause a range of eye problems, including cataracts, glaucoma, and corneal abnormalities.
If you or someone you know is experiencing symptoms of ASMD, a genetic DNA test can help to determine if the condition is caused by a mutation in the PITX3 gene. DNA Labs India offers an NGS (next-generation sequencing) genetic test for the PITX3 gene at a cost of INR 20,000.
Symptoms of ASMD
The symptoms of ASMD can vary depending on the specific genetic mutation involved. Some common symptoms include:
- Cataracts
- Glaucoma
- Corneal abnormalities
- Small or absent iris
- Nystagmus (involuntary eye movement)
- Reduced visual acuity
Diagnosis of ASMD
ASMD is typically diagnosed based on a combination of clinical evaluation and genetic testing. An ophthalmologist will perform a comprehensive eye exam to assess for the characteristic eye abnormalities associated with ASMD. If ASMD is suspected, genetic testing can be performed to identify a mutation in the PITX3 gene.
NGS Genetic DNA Test
The NGS genetic DNA test offered by DNA Labs India is a powerful tool for identifying mutations in the PITX3 gene. NGS allows for the simultaneous sequencing of multiple genes, providing a comprehensive evaluation of the genetic mutations that may be contributing to ASMD. This test has a cost of INR 20,000.
If you or someone you know is experiencing symptoms of ASMD, it is important to seek a diagnosis as soon as possible. A genetic DNA test can help to identify the underlying genetic mutation and guide treatment decisions. Contact DNA Labs India to learn more about our NGS genetic DNA test for the PITX3 gene.
Looking for a reliable genetic DNA test provider for Anterior segment mesenchymal dysgenesis (ASMD)? DNA Labs India offers a cost-effective NGS genetic DNA test for the PITX3 gene, which can help to identify the underlying genetic mutation causing ASMD. Learn more about ASMD symptoms, diagnosis, and treatment options in our latest blog post. Contact us today to schedule your genetic DNA test for ASMD.
Before getting tested ask for Raw Data, FASTQ, and VCF files along with clinical test report from DNA Testing Lab. DNA Labs India is the Only lab that is transparent and will share Raw Data, FASTQ, and VCF files along with the conclusive clinical report for PITX3 Gene Anterior segment mesenchymal dysgenesis NGS Genetic DNA Test
Sample Collection
No special preparation is required. Clinical history and family pedigree information should be provided before the test.
Method: Blood draw or FTA card spot or DNA submission
Laboratory Analysis
A qualified phlebotomist will collect a blood sample, or a blood spot may be placed on an FTA card, depending on the chosen test kit.
Report Delivery
You may resume normal activities immediately after sample collection. No specific post-collection precautions are needed.
Timeline: 3 to 4 weeks
Patient Instructions
About This Test
Who Should Get This Test
The purpose of this NGS genetic test is to identify mutations in the PITX3 gene in individuals with clinical features suggestive of anterior segment mesenchymal dysgenesis. It provides a molecular diagnosis, assists in recurrence risk counseling, and helps guide clinical monitoring for associated ocular complications such as glaucoma and cataracts.
NGS genetic DNA test detecets for variant and mutation detection in PITX3 gene for Anterior segment mesenchymal dysgenesis
How to Prepare
- No fasting required
- Provide clinical history and family pedigree before sample collection
- Use an EDTA vial for whole blood or FTA card for dried blood spot
- Label the sample with full name, date of birth, and collection date
Doctor's Notes
Reviewed by Dr SULOCHANA HEMCHANDRA HOLLA — MBBS, MD (Medical Genetics) · Reg. No. 8532
"Clinically, anterior segment findings can be subtle in early childhood. A molecular diagnosis of PITX3-related ASMD helps ophthalmologists anticipate cataract surgery outcomes, monitor for glaucoma, and offer clear recurrence-risk counseling to the family."
Last updated: September 7, 2026
Test Parameters & Specifications
Sample Stability
- Sample tube not labeled properly
- Insufficient blood volume or DNA concentration
- Sample received in incorrect anticoagulant tube
- Clinical history and consent not provided
- Suspected sample degradation
Understanding Your Results
Positive for a pathogenic/likely pathogenic PITX3 variant
Consistent with a molecular diagnosis of PITX3-related anterior segment mesenchymal dysgenesis.
Negative: no pathogenic variant detected
Reduced likelihood of PITX3-related ASMD; other genetic causes should be considered.
Variant of uncertain significance (VUS)
Insufficient evidence to determine clinical significance; additional family testing may be recommended.
Benign/likely benign variant
Not considered disease-causing.
If the test identifies a pathogenic or likely pathogenic PITX3 variant, consult a clinical geneticist and an ophthalmologist to discuss surveillance, treatment, and family testing. If a variant of uncertain significance is found, follow up with genetic counseling and segregation studies in family members.
Limitations
- ⚠This test is limited to the PITX3 gene and may not detect mutations in other genes associated with anterior segment dysgenesis
- ⚠Large structural rearrangements, copy number variants, and deep intronic mutations may not be detected by this NGS assay
- ⚠Variants of uncertain significance may require additional family studies and functional evidence
Risks & Considerations
- ●Minor bruising at the blood collection site
- ●Dizziness or lightheadedness during blood draw
- ●Rare risk of local infection
Interfering Factors
- ●Low-quality or degraded DNA may reduce assay sensitivity
- ●Variants in pseudogenes or highly homologous regions may complicate sequencing
- ●Incomplete clinical information may limit variant interpretation
- ●Rare intronic or regulatory variants may not be detected by standard exonic NGS
Frequently Asked Questions
What is anterior segment mesenchymal dysgenesis (ASMD)?
What is the PITX3 gene?
How is the PITX3 NGS genetic test performed?
What is the cost of the test?
What sample type is required?
Do I need to fast?
When will I get the report?
Will I receive raw data, FASTQ and VCF files?
Who should consider this test?
What do positive or negative results mean?
Does this test detect all causes of ASMD?
Is home sample collection available?
Related Tests
Leber's Hereditary Optic Neuropathy (LHON) Mitochondrial Mutation Detection Test
₹25,000Nx Gen Sequencing: Cataract Test
₹28,665Nx Gen Sequencing: Glaucoma Test
₹28,665Nx Gen Sequencing: Corneal Dystrophy Test
₹28,665Nx Gen Sequencing: Leber Congenital Amaurosis Test
₹28,665Nx Gen Sequencing: Ophthalmoplegia Test
₹28,665Reference Laboratory Services
We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.
Your Data Privacy
Your medical data is protected under Indian law.
✓ Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.
✓ DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.
Book Your Test
Enter your details and we'll connect you within 15 minutes.